Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance.
- NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_assertion description "[Embedded in this study was peripheral blood sampling for TMPRSS2-ERG and SPINK1, two genes that are believed to define prostate cancer genotypes, to assess their utility as biomarkers This study suggests that at the delivered doses, cytarabine has limited efficacy and significant myelotoxicity suggesting, it does not have a role in the treatment of docetaxel-refractory CRPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance.
- NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_assertion evidence source_evidence_literature NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance.
- NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_assertion SIO_000772 22313860 NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance.
- NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_assertion wasDerivedFrom befree-2016 NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance.
- NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_assertion wasGeneratedBy ECO_0000203 NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance.
- befree-2016 importedOn "2016-02-19" NP959259.RAgKKWsGUpzNXphVVV1eHLO9HbhETa4h9_7N41DQbyCXw130_provenance.